Skip to main content
Top
Published in: Reactions Weekly 1/2023

01-06-2023 | Ritonavir | Case report

Multiple drugs

Various toxicities: 9 case reports

Published in: Reactions Weekly | Issue 1/2023

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is: Drug interaction
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Gonzalez-Garcia R, et al. Drug-drug interactions of ritonavir-boosted SARS-CoV-2 protease inhibitors in solid organ transplant recipients: experience from the initial use of lopinavir-ritonavir. Clinical Microbiology and Infection 29: 655e1-655e4, No. 5, 2023. Available from: URL: http://doi.org/10.1016/j.cmi.2023.01.002 Gonzalez-Garcia R, et al. Drug-drug interactions of ritonavir-boosted SARS-CoV-2 protease inhibitors in solid organ transplant recipients: experience from the initial use of lopinavir-ritonavir. Clinical Microbiology and Infection 29: 655e1-655e4, No. 5, 2023. Available from: URL: http://​doi.​org/​10.​1016/​j.​cmi.​2023.​01.​002
Metadata
Title
Multiple drugs
Various toxicities: 9 case reports
Publication date
01-06-2023
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-41981-6

Other articles of this Issue 1/2023

Reactions Weekly 1/2023 Go to the issue

Case report

Azathioprine

Case report

Multiple drug

Case report

Prednisolone

Case report

Multiple drugs